Argus analyst Kevin Heal raised the firm’s price target on Nasdaq (NDAQ) to $88 from $82 and keeps a Buy rating on the shares. The company’s ...
Palantir’s surge in stock price shows strong AI growth, but insiders are profiting. Read why PLTR stock may struggle as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback